Illumina Ventures sets out for $300M third fund
A venture firm with Illumina as its majority investor is charging ahead with its next batch of capital as the DNA sequencing company endeavors on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
